Risk-reducing salpingo-oophorectomy

Results 181 to 190 of about 7,404 (210)

Some of the next articles are maybe not open access.

Review Article: Sexuality and Risk-Reducing Salpingo-oophorectomy.

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 2018
Women with familial cancer syndromes such as hereditary breast and ovarian cancer syndrome (BRCA1 and BRCA2) and Lynch syndrome are at a significantly increased risk of developing ovarian cancer and are advised to undergo prophylactic removal of their ovaries and fallopian tubes at age 35 to 40 years, after childbearing is complete.A comprehensive ...
Paige E, Tucker, Paul A, Cohen
openaire +1 more source

Non-cancer endpoints in BRCA1/2 carriers after risk-reducing salpingo-oophorectomy

Familial Cancer, 2011
Risk-reducing salpingo-oophorectomy (RRSO) significantly reduces the risk of ovarian cancer and breast cancer in pre-menopausal women with BRCA1 and BRCA2 (B1/2) mutations. Despite its clear benefits, little is known about non-cancer endpoints in this population.
J V, Cohen +8 more
openaire +2 more sources

Does risk-reducing bilateral salpingo-oophorectomy leave behind residual tube?

Gynecologic Oncology, 2010
Risk-reducing bilateral salpingo-oophorectomy (RRSO) is an effective option for women with BRCA mutations however there is limited information as to how much tubal epithelium remains after RRSO.Twenty hysterectomy specimens were prospectively evaluated after both tubes were fulgurated and transected at the uterine cornua in an attempt to remove the ...
Ilana, Cass, Ann, Walts, Beth Y, Karlan
openaire +2 more sources

CA125 screening after risk-reducing salpingo-oophorectomy

Menopause, 2011
Leslie S. Bradford, John O. Schorge
openaire +1 more source

Risk-Reducing Salpingo-Oophorectomy for BRCA Carriers